⌘K (Command K) to search

Sign in Sign up free

10-KAccepted Feb 19, 5:51 PM ET

GENENTECH INC 10-K

sec.gov View full filing

Accepted (ET)

5:51 PM

Feb 19, 2009

Filed

Feb 20, 2009

Documents

10

Size

4.0 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.

Filing details

Company: GENENTECH INC
CIK: 0000318771
Form: 10-K
Accepted: Feb 19, 5:51 PM ET
Filed: Feb 20, 2009
Size: 4.0 MB
Accession: 0000318771-09-000003

Documents · 10

form10-k_2008.htmPrimary
GENENTECH, INC. FORM 10-K FOR THE PERIOD ENDING DECEMBER 31, 2008
ex10_9.htm
GENENTECH, INC. TAX REDUCTION INVESTMENT PLAN, AS AMENDED AND RESTATED
ex10_19.htm
AMENDMENT NO. 1 TO GENENTECH, INC. SUPPLEMENTAL PLAN
ex10_20.htm
AMENDMENT NO. 2 TO GENENTECH, INC. SUPPLEMENTAL PLAN
ex10_21.htm
AMENDMENT NO. 3 TO GENENTECH, INC. SUPPLEMENTAL PLAN
ex23_1.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ex31_1.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14(A) PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
ex31_2.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14(A) PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
ex32_1.htm
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
graph_10k2008.gif
PERFORMANCE GRAPH